A new study shows that oral fecal microbiota transplantation (FMT) is a feasible and safe addition to preventing graft-versus-host disease in patients undergoing stem cell transplantation for blood ...

FMT shows promise in helping children with autism by restructuring gut bacteria, which can significantly reduce ...

Our understanding of the brain-gut connection is increasing by the day. For example, some individuals with autism spectrum disorder (ASD) also experience gastrointestinal symptoms which correlate with ...

A single fecal microbiota transplant in obese teens was linked to long-lasting metabolic improvements, including smaller waistlines, reduced body fat, lower inflammation, and better cholesterol levels ...

Please provide your email address to receive an email when new articles are posted on . FMT appeared as effective as vancomycin in curing first-time C. difficile infection. Findings show FMT has ...

Add Yahoo as a preferred source to see more of our stories on Google. Illustration of intestinal bacteria. There's growing evidence that the mix of bacteria in the gut affects obesity risk, and new ...

Fecal microbiota transplantation (FMT), shown to be effective in the treatment of recurrent Clostridioides difficile infection (CDI), also shows significant benefit in the treatment of primary CDI, ...

In a new study, a fecal microbiota sample taken when eight mice were young and transplanted later to the same mice was associated with fewer cancers, less DNA damage, and longer telomere lengths. The ...

Add Yahoo as a preferred source to see more of our stories on Google. Tim Story, a high school football coach and teacher in Hattiesburg, Miss., was diagnosed with cancer in 2022. (Annie Flanagan for ...

The gut microbiota plays a crucial role in maintaining host health and liver function. Fecal microbiota transplantation (FMT), an emerging therapeutic modality, has demonstrated promising potential in ...

Fecal microbiota transplant was noninferior to vancomycin as the initial treatment for C. diff in a randomized, open-label trial. Transplant showed slightly higher cure rates without recurrence and ...